Serial blood sampling effects in rat embryo-fetal development studies for toxicokinetics

Area of Science:

• Reproductive toxicology
• Developmental toxicology
• Pharmacokinetics

Background:

• Regulatory embryo-fetal development (EFD) studies in rats require serial blood sampling for toxicokinetics.
• Assessing pharmaceutical effects on pregnant females and fetuses necessitates understanding exposure-toxicity relationships.
• Limited data exists on the impact of serial blood sampling on pregnant animals.

Purpose of the Study:

• To investigate the physiological impact of serial blood sampling in pregnant rats within a standard EFD study design.
• To evaluate sensitive endpoints like clinical pathology, organ weights, and histopathology following blood collection.
• To inform the design of regulatory EFD studies regarding blood sampling procedures.

Main Methods:

• Pregnant rats underwent serial blood sampling mimicking a typical EFD study protocol.
• Clinical pathology, organ weights, and histopathology were assessed as potential indicators of sampling effects.
• Comparison of endpoints between groups with and without serial blood sampling.

Main Results:

• Serial blood sampling induced physiological adaptive changes in pregnant rats.
• No significant impact was observed on the general endpoints evaluated in the EFD studies.
• Sensitive endpoints did not reveal adverse effects directly attributable to blood collection.

Conclusions:

• While serial blood sampling in pregnant rats shows physiological adaptation, it does not compromise general EFD study outcomes.
• The use of satellite groups in EFD studies is recommended for a more cautious approach.
• This research provides crucial data for optimizing the design of regulatory EFD studies and assessing pharmaceutical safety.